658MO Cisplatin (cis)-related immunomodulation and efficacy with atezolizumab (atezo) + cis- vs carboplatin (carbo)-based chemotherapy (chemo) in metastatic urothelial cancer (mUC)

Autor:	M. De Santis, Javier Arranz, Li Wang, Chooi Peng Lee, Eiji Kikuchi, R.H. Herbst, X. Shen, E. Hajaj, Jingbin Zhang, Peter C. Black, X. Guan, H. Yu, Matthew D. Galsky, Aristotle Bamias, Ian D. Davis, Enrique Grande, Jun Zhu, Deepali Rishipathak, Sanjeev Mariathasan, Romain Banchereau
Rok vydání:	2021
Předmět:	Cisplatin Chemotherapy business.industry medicine.medical_treatment Hematology Carboplatin chemistry.chemical_compound Oncology chemistry Atezolizumab medicine Cancer research Urothelial cancer business medicine.drug
Zdroj:	Annals of Oncology. 32:S682-S683
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.054
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::571a879af89d7acbc29a2881ea988ad9 https://doi.org/10.1016/j.annonc.2021.08.054 Zobrazit plný text záznamu